Economic Analysis of the Chemo Mouthpiece® Medical Device Suggests Potential Cost Savings of Over $15,000 per Patient Receiving Chemotherapy and Reduced Healthcare Resource Utilization

Peer-reviewed study highlights modeled economic and clinical impact associated with use of the Chemo Mouthpiece® oral cooling device in adult patients receiving chemotherapy. WILMINGTON, Del., July 22, 2026 /PRNewswire/ -- Chemomouthpiece, LLC, a privately held medical device company...